CpG-island methylation study of liver fluke-related cholangiocarcinoma

British Journal of Cancer

Volumn 104, Issue 8, 2011, Pages 1313-1318

  Sriraksa, R ^a   Zeller, C ^b   El Bahrawy, M A ^b   Dai, W ^b   Daduang, J ^a   Jearanaikoon, P ^a   Chau In, S ^a   Brown, R ^b   Limpaiboon, T ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

biomarkers; cholangiocarcinoma; DcR1; DNA methylation; liver fluke; OPCML

Indexed keywords

TUMOR MARKER;

ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FASCIOLA HEPATICA; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROSEQUENCING; RESTRICTION MAPPING;

AGED; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 79954430215     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.102     Document Type: Article

References (49)

1. Besson A, Robbins SM, Yong VW (1999) PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 263: 605-611 (Pubitemid 29361932)
2. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437-448 (Pubitemid 41546674)
3. Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T (2009) Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Hum Pathol 40: 817-826
4. Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, Loyo M, Chan AT, Srivastava G, Tsao GS, Sellar GC, Sung JJ, Sidransky D, Tao Q (2008) OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3: e2990
5. Esteller M (2006) Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94: 179-183 (Pubitemid 43151531)
6. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS (1997) Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 94: 6770-6775 (Pubitemid 27281939)
7. Fleuriel C, Touka M, Boulay G, Guerardel C, Rood BR, Leprince D (2009) HIC1 (hypermethylated in cancer 1) epigenetic silencing in tumors. Int J Biochem Cell Biol 41: 26-33
8. Gutierrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, Bhatia K (2004) CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol 17: 1268-1274 (Pubitemid 39312953)
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826 (Pubitemid 26296693)
10. Honjo S, Srivatanakul P, Sriplung H, Kikukawa H, Hanai S, Uchida K, Todoroki T, Jedpiyawongse A, Kittiwatanachot P, Sripa B, Deerasamee S, Miwa M (2005) Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 117: 854-860 (Pubitemid 41599908)
11. Hussain F, Wang J, Ahmed R, Guest SK, Lam EW, Stamp G, El-Bahrawy M (2010) The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours. Cytokine 49: 134-140
12. IARC (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61: 1-241
13. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150 (Pubitemid 46655601)
14. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366: 1303-1314 (Pubitemid 41416587)
15. Lee S, Kim WH, Jung HY, Yang MH, Kang GH (2002) Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol 161: 1015-1022 (Pubitemid 34988389)
16. Limpaiboon T, Khaenam P, Chinnasri P, Soonklang M, Jearanaikoon P, Sripa B, Pairojkul C, Bhudhisawasdi V (2005) Promoter hypermethyla-tion is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. Cancer Lett 217: 213-219 (Pubitemid 40023120)
17. Limpaiboon T, Krissadarak K, Sripa B, Jearanaikoon P, Bhuhisawasdi V, Chau-in S, Romphruk A, Pairojkul C (2002) Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis. Cancer Lett 181: 215-222 (Pubitemid 34518307)
18. Limpaiboon T, Sripa B, Wongkham S, Bhudhisawasdi V, Chau-in S, Teerajetgul Y (2004) Anti-p53 antibodies and p53 protein expression in cholangiocarcinoma. Hepatogastroenterology 51: 25-28 (Pubitemid 38283053)
19. Liu S, Ren S, Howell P, Fodstad O, Riker AI (2008) Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res 21: 545-558
20. Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF (2006a) Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma. Ai Zheng 25: 696-700
21. Liu XF, Zhang H, Zhu SG, Zhou XT, Su HL, Xu Z, Li SJ (2006b) Correlation of p53 gene mutation and expression of P53 protein in cholangiocarci-noma. World J Gastroenterol 12: 4706-4709 (Pubitemid 44269731)
22. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274 (Pubitemid 46962095)
23. McNamee CJ, Reed JE, Howard MR, Lodge AP, Moss DJ (2002) Promotion of neuronal cell adhesion by members of the IgLON family occurs in the absence of either support or modification of neurite outgrowth. J Neurochem 80: 941-948 (Pubitemid 34809946)
24. Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Umansky SR (1997) SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 94: 13636-13641
25. Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19: 1228-1234
26. Nakanuma Y, Sripa B, Vatanasapt V, Leong ASY, Ponchon T, Ishak KG (2000) Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA. (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive system. pp 173-180. IARC Press: Lyon
27. Nicoll G, Crichton DN, McDowell HE, Kernohan N, Hupp TR, Thompson AM (2001) Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer 85: 1878-1882 (Pubitemid 34775324)
28. Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, Yoshimura A, Ko S, Kin T, Yagura K, Konishi Y, Nakano H (1995) Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarci-nomas: relation to gross tumor morphology. Gastroenterology 109: 1612-1617
29. Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2: 10
30. Patel T (2006) Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3: 33-42 (Pubitemid 43102075)
31. Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D, Brown I, Williams AR, Bates PA, Smyth JF, Gabra H (2003) OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet 34: 337-343 (Pubitemid 36792869)
32. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125 (Pubitemid 38738341)
33. Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF (2004) Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 109: 786-792 (Pubitemid 38405630)
34. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM (2004) Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 9: 588-594 (Pubitemid 38657284)
35. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4: e201
36. Sriraksa R, Chaopatchayakul P, Jearanaikoon P, Leelayuwat C, Limpaiboon T (2010) Verification of complete bisulfite modification using calponin-specific primer sets. Clin Biochem 43: 528-530
37. Sulis ML, Parsons R (2003) PTEN: from pathology to biology. Trends Cell Biol 13: 478-483 (Pubitemid 37289398)
38. Suzuki M, Shigematsu H, Shivapurkar N, Reddy J, Miyajima K, Takahashi T, Gazdar AF, Frenkel EP (2006) Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett 242: 222-230 (Pubitemid 44485305)
39. Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y (2008) Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 43: 378-389 (Pubitemid 351958902)
40. Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, Uhlmann D, Hauss J, Wittekind C (2002) Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol 197: 624-631
41. Teodoridis JM, Hall J, Marsh S, Kannall HD, Smyth C, Curto J, Siddiqui N, Gabra H, McLeod HL, Strathdee G, Brown R (2005) CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res 65: 8961-8967 (Pubitemid 41377387)
42. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S (1978) Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 38: 4634-4639 (Pubitemid 9065143)
43. Thamavit W, Kongkanuntn R, Tiwawech D, Moore MA (1987) Level of Opisthorchis infestation and carcinogen dose-dependence of cholangio-carcinoma induction in Syrian golden hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol 54: 52-58 (Pubitemid 17146207)
44. Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A, Wittekind C, Hengge UR, Tannapfel A (2005) Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 115: 684-689 (Pubitemid 40776690)
45. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20: 3348-3353 (Pubitemid 32588983)
46. van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG, Versteeg R (2002) Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res 62: 2157-2161 (Pubitemid 34408465)
47. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577
48. Yang B, House MG, Guo M, Herman JG, Clark DP (2005) Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol 18: 412-420 (Pubitemid 40395361)
49. Ye F, Zhang SF, Xie X, Lu WG (2008) OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma. Cancer Invest 26: 569-574 (Pubitemid 351918578)